The new company, Cordavis, will operate as 'a wholly owned subsidiary that will work directly with manufacturers to commercialize and/or co-produce biosimilar products.'
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
